President of the Russian Academy of Sciences : multiple COVID-19 vaccines available are key to success

President of the Russian Academy of Sciences Alexander Sergeev is confident that the presence of several different vaccines against the SARS-CoV-2 virus, thanks to which it is possible to inoculate a wide variety of population groups, depending on medical indications, will become a factor capable of stopping the coronavirus pandemic, RIA Novosti reports.

According to Sergeev, a person may have a chronic disease or a predisposition to any disease. Plus, vaccinated people have different ages. All this requires the selection of a specific vaccine for each patient. "And, the more vaccines there are, the better doctors will be able to determine what is needed in a particular case and apply it in a targeted manner. Probably, this will ultimately stop the pandemic," says Sergeyev.

Recall: in early August, the Ministry of Health registered the Sputnik V vaccine for the prevention of COVID-19 by the N.F. Gamalei. In the summer, the vaccine went through two stages of testing on volunteers 18-60 years old, forming their immune response and antibodies to SARS-CoV-2. To date, Russia has agreed to produce vaccines not only for the domestic but also for the foreign market.

The post-registration phase of clinical trials, involving 40,000 people, began in September. Today, research has been approved in the UAE, Russia, and Belarus. Also recently, the Ministry of Health began to register the second domestic vaccine - "EpiVacCorona".